Components Below Will Be Removed. Copy and paste them as needed for this page.

Why Watch?
Insert Image here
Marc Shapiro
Managing Director

Mr. Shapiro has over 20 years of experience in all aspects of analysis and valuation of commercial real estate. He specializes in the valuation of individual properties and portfolios for financial reporting, lending, estate planning, gifting, partnership issues, eminent domain, purchase price allocations, ad valorem taxation, litigation support, public offerings, and portfolio analysis and in providing litigation support related to valuation issues.
Marc Shapiro
Managing Director

Mr. Shapiro has over 20 years of experience in all aspects of analysis and valuation of commercial real estate. He specializes in the valuation of individual properties and portfolios for financial reporting, lending, estate planning, gifting, partnership issues, eminent domain, purchase price allocations, ad valorem taxation, litigation support, public offerings, and portfolio analysis and in providing litigation support related to valuation issues.
Nullam nec hendrerit metus. Aliquam laoreet malesuada pellentesque. Donec a felis turpis. Sed rhoncus, elit a adipiscing pellentesque, mi elit pharetra nulla, sit amet aliquet ipsum ligula vitae nibh. Morbi a dolor sagittis, pellentesque erat a, varius orci. Morbi faucibus est vitae pulvinar molestie. Integer at erat sit amet enim volutpat dignissim.

Cras pellentesque
Sed ultricies tempor dolor. Morbi interdum blandit lacus. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec molestie pellentesque semper. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Aenean mollis elit in euismod sollicitudin.
Header
Transforming Purchased Services through Analytics
MARKET UPDATE WEBINAR
What is Happening to Real Estate Values?

A presentation and review of factors contributing to real estate values and the identification of current trends and expectations for future appreciation.
Date
Wednesday, September 29 2013
Time
12:30 PM ET
Length
60 mins
Location
123 FTI Laneway Boulevard, Ontario Canada N3A 2V2
8:30 AM Registration
9:00 AM Brunch / Range opens
11:00 AM Golf Tournament / Shot-gun start
1:00 PMGolf Clinic
4:00 PMCocktail and dinner reception
Register Here
Form Title
Optional form description copy goes here.
Medication safety has long been one of the Joint Commission’s key priorities. Its importance has recently been brought into public focus by the news of criminal charges against a registered nurse in Tennessee who was involved in a fatal medication error.

These errors can pose grave risks not only for patients and caregivers, but also for a Hospital’s reputation and Medicare reimbursement status.

FTI Consulting, in this joint presentation with Aspirus Health System, challenges hospital executives and pharmacy leaders to take a closer look at their safety culture and systems in place to increase error reporting and reduce the likelihood of medication errors reaching patients.

We will discuss American Society of Health System Pharmacy and Institute for Safe Medication Practices recommendations — such as consistent use of barcoding and leveraging of multidisciplinary medication safety committees — to help reduce risks to patients, employees and your organization.
Learn About:
Who Should Watch?
  • Hospital C-Suite interested in reducing medication error risk
  • Directors and VPs of Pharmacy
  • Chief Medical Officers
  • VPs of Quality/Risk Management
Presenters
Jigar Thakkar, PharmD, MBA
Managing Director
FTI Consulting Health Solutions
jigar.thakkar@fticonsulting.com

Jigar Thakkar is a Managing Director at FTI Consulting. He is part of the Health Solutions segment within the Healthcare Operations practice, where he specializes in Pharmacy.  Jigar’s experience in Pharmacy includes strategic planning, design, operations, compliance, and improvement of an organization’s medication management system.  He has experience in implementing best practice pharmacy models and has expertise in pharmacy supply chain management, pharmacy productivity, and pharmacy related regulatory and accreditation compliance such as the 340B Drug Pricing Program.

Jigar has a broad range of pharmacy experience in addition to the hospital segment that includes Retail, Specialty, Infusion, Hematology/Oncology, Long Term Care, Capital Equity directed projects of regulatory due diligence of mergers and acquisitions of large retail and specialty pharmacy chains.  Jigar has also completed several projects of large health system mergers as they relate to pharmacy integration and implementation of resulting synergies. 
REPLAY: LUNCH WITH FTI
Medication Safety: Ensuring Your Health System Has Implemented an Impactful Medication Safety Program
Date Presented
Wednesday, June 19, 2019
 

Length
30 mins

  • Foundational Medication Safety Program Tasks
  • Medication Safety Committee
  • Typical Downfalls in Practice
Jessica Bessner, PharmD, BCGP
Director of Pharmacy
Aspirus Keweenaw Hospital
Jessica.Bessner@aspirus.org

Jessica Bessner is a Pharmacy Director at Aspirus Keweenaw Hospital and the current President of the Michigan Pharmacists Association. Her responsibilities include two hospital pharmacies and two retail pharmacies as well as Long Term Care medication provision and consulting.   Jessica's experience in Pharmacy includes leadership, project management, operations, medication safety, 340b analytics, and automation in both the nonprofit and for-profit sectors.